| Amphetamine decorated cationic lipid nanoparticles cross the blood–brain barrier: therapeutic promise for combating glioblastoma S Saha, V Yakati, G Shankar, MMCS Jaggarapu, G Moku, ... Journal of Materials Chemistry B 8 (19), 4318-4330, 2020 | 43 | 2020 |
| In vivo Targeting of DNA Vaccines to Dendritic Cells via the Mannose Receptor Induces Long‐Lasting Immunity against Melanoma G Moku, S Vangala, SK Gulla, V Yakati ChemBioChem 22 (3), 523-531, 2021 | 29 | 2021 |
| Systemic codelivery of a homoserine derived ceramide analogue and curcumin to tumor vasculature inhibits mouse tumor growth S Barui, S Saha, V Yakati, A Chaudhuri Molecular Pharmaceutics 13 (2), 404-419, 2016 | 23 | 2016 |
| Combating Established Mouse Glioblastoma through Nicotinylated‐Liposomes‐Mediated Targeted Chemotherapy in Combination with Dendritic‐Cell‐Based Genetic Immunization S Saha, Y Venu, D Bhattacharya, SD Kompella, K Madhusudana, ... Advanced Biosystems 1 (1-2), 1600009, 2017 | 17 | 2017 |
| Enhancing the anticancer effect of paclitaxel by using polymeric nanoparticles decorated with colorectal cancer targeting CPKSNNGVC-peptide V Yakati, S Vangala, VS Madamsetty, R Banerjee, G Moku Journal of Drug Delivery Science and Technology 68, 103125, 2022 | 12 | 2022 |
| Glucocorticoid receptor-targeted liposomal delivery system for delivering small molecule ESC8 and anti-miR-Hsp90 gene construct to combat colon cancer S Jinka, HK Rachamalla, T Bhattacharyya, K Sridharan, ... Biomedical Materials 16 (2), 024105, 2021 | 9 | 2021 |
| Enriched pharmacokinetic behavior and antitumor efficacy of thymoquinone by liposomal delivery HK Rachamalla, S Bhattacharya, A Ahmad, K Sridharan, VS Madamsetty, ... Nanomedicine 16 (8), 641-656, 2021 | 6 | 2021 |
| Glioblastoma mechanobiology at multiple length scales RV Kondapaneni, SK Gurung, PS Nakod, K Goodarzi, V Yakati, NA Lenart, ... Biomaterials Advances, 213860, 2024 | 2 | 2024 |
| In vivo targeting of a tumor-antigen encoded DNA vaccine to dendritic cells in combination with tumor-selective chemotherapy eradicates established mouse melanoma S Barui, S Saha, Y Venu, GK Moku, A Chaudhuri Biomaterials Science 11 (18), 6135-6148, 2023 | 2 | 2023 |
| Novel Suberoylanilide Hydroxamic Acid Analogs Inhibit Angiogenesis and Induce Apoptosis in Breast Cancer Cells G Moku, S Vangala, V Yakati, CC Gali, S Saha, VS Madamsetty, A Vyas Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2022 | 1 | 2022 |
| Integrin receptor-targeted, doxorubicin-loaded cerium oxide nanoparticles delivery to combat glioblastoma G Koula, V Yakati, HK Rachamalla, K Bhamidipati, M Kathirvel, ... Nanomedicine 19 (15), 1389-1406, 2024 | | 2024 |
| Matrix stiffness influences response to chemo and targeted therapy in brain metastatic breast cancer cells V Yakati, LA Shevde, SS Rao Biomaterials Science, 2024 | | 2024 |
| Magnetic Quantum Dots for In-Vivo Imaging V Yakati, S Vangala, VJ Reddy, B Gidwani, A Vyas, V Jain, V Joshi, ... Magnetic Quantum Dots for Bioimaging, 227-240, 2023 | | 2023 |
| Surface Modified Glucose‐Derived, Blood–Brain Barrier‐Crossing Nanospheres Dually Targets Macrophage and Cancer Cells for Effective In Situ Anti‐Glioma Effect MMCS Jaggarapu, A Ansari, S Jinka, K Sridharan, NV Nimmu, N Mahadik, ... Advanced Therapeutics, 2400100, 0 | | |
| Liposomal drug carriers for selective targeting of cancer therapeutics to glioblastoma and colorectal cancer V Yakati Ghaziabad, 0 | | |
| The Immunomodulatory Effects on Tumor-Associated Macrophages by Integrin Receptor-Targeted Delivery of Doxorubicin-Loaded Cerium Oxide Nanoparticles to Combat Glioblastoma G Koula, V Yakati, HK Rachamalla, K Bhamidipati, M Kathirvel, ... Available at SSRN 4500354, 0 | | |
